Calithera Biosciences (CALA) Competitors

Calithera Biosciences (NASDAQ:CALA) and Athersys (NASDAQ:ATHX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation.

Do institutionals and insiders hold more shares of CALA or ATHX?

19.4% of Athersys shares are held by institutional investors. 6.6% of Calithera Biosciences shares are held by insiders. Comparatively, 0.0% of Athersys shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is CALA or ATHX more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Calithera Biosciences	N/A	N/A	N/A
Athersys	N/A	N/A	-223.03%

Which has stronger earnings & valuation, CALA or ATHX?

Calithera Biosciences has higher revenue and earnings than Athersys.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Calithera Biosciences	$9.75M	0.00	-$39.65M	N/A	N/A
Athersys	$146K	2.54	-$72.53M	-$2.03	0.00

Does the media favor CALA or ATHX?

In the previous week, Calithera Biosciences and Calithera Biosciences both had 1 articles in the media. Calithera Biosciences' average media sentiment score of 0.00 equaled Athersys'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Calithera Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Athersys	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts prefer CALA or ATHX?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Calithera Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Athersys	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community believe in CALA or ATHX?

Athersys received 24 more outperform votes than Calithera Biosciences when rated by MarketBeat users. Likewise, 60.23% of users gave Athersys an outperform vote while only 59.30% of users gave Calithera Biosciences an outperform vote.

Company	Underperform	Outperform
Calithera Biosciences	Outperform Votes 341 59.30%	Underperform Votes 234 40.70%
Athersys	Outperform Votes 365 60.23%	Underperform Votes 241 39.77%

Summary

Calithera Biosciences and Athersys tied by winning 4 of the 8 factors compared between the two stocks.